BRAF基因突变对结肠癌伴随胃癌发生的影响

全文: PDF(3076 KB)
输出: BibTeX | EndNote (RIS)

摘要目的研究BRAF基因突变与结肠癌伴随胃癌，以及PRDX1和PRDX6基因表达量的关联，分析PRDX1和PRDX6基因在结肠癌伴随其它原发癌症中的作用。方法收集47例患有结肠癌与伴随胃癌病人的样本，通过PNAClampTM突变检测试剂盒检测样本中BRAF和MLH1基因的突变情况，利用卡方检验比较突变与相关特征的关系。通过qPCR和蛋白质印迹检测BRAF突变样本中的PRDX1和PRDX6的表达量变化。通过人类HCT-116结肠癌细胞中转入带有BRAF突变的质粒，研究细胞系水平BRAF突变对PRDX 1和PRDX 6表达量的影响。结果 BRAF的突变在不同年龄、癌症位置、多发癌时间间距、癌症数量或者家庭癌症史之间差异无显著性(P>0.05);而MLH1的突变在不同多发癌时间间距、癌症数量和家庭癌症史之间，差异有显著性(P<0.05)。PRDX1和PRDX6表达水平与BRAF突变程度及不同结肠癌伴随的原发癌数量之间差异有显著性(P<0.05)，PRDX1和PRDX6基因可能是BRAF突变抑制的目标。结论结肠癌伴随胃癌的多种原发性癌症中BRAF突变率比较低。使用BRAF突变作为鉴定标记，仍需要其他基因如MLH1基因突变情况的辅助。BRAF突变可以抑制PRDX1和PRDX6基因的表达，而且PRDX1和PRDX6基因的表达量与结肠癌伴随的原发癌的数量有关。

	服务

	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ： BRAF, MLH1, PRDX1, PRDX6, 结肠癌, 多种原发性癌症

Abstract：Objective To investigate the association between BRAF mutation and colon cancer with stomach cancer, and between BRAF mutation and gene expression of PRDX6 and PRDX1, and to analyze the role of PRDX1 and PRDX6 gene in colon cancer with other primary cancers.Methods A total of 47 patients with colon cancer complicated by gastric cancer samples were collected. Mutation of BRAF and MLH1 genes were detected by PNAClampTM kit, and chi-square test was used to compare the relationship between mutations and related characteristics. Expressions of PRDX1 and PRDX6 were quantified by qPCR and Western blot in samples with and without BRAF mutation. The plasmid with the BRAF mutation was transferred into human HCT-116 colon cancer cells to investigate the expression levels of PRDX1 and PRDX6.Results BRAF mutation had no correlation with age, cancer location, multiple cancer time intervals and the number of cancer or family history of cancer; while MLH1 mutation had correlation with cancer multiple time intervals and the number of cancer and family cancer history (P<0.05). PRDX1 and PRDX6 expression levels were correlated with the degree of the BRAF mutation and the number of primary cancer in colon cancer (P<0.05). PRDX1 and PRDX6 might be the target of BRAF mutation inhibition.Conclusion BRAF mutation rate in colon cancer complicated by gastric cancer is relatively low in the Chinese population. When using BRAF mutation as a marker for detection, other genes such as MLH1 gene mutation may be as auxiliary. BRAF mutation inhibits PRDX1 and PRDX6, which in turn may affect the number of primary cancer.

Key words： BRAF MLH1 colon cancer multiple primary cancer

出版日期: 2016-09-14

作者简介: 周海洋(1977-)，男，硕士，主治医师。从事胃肠外科、肛肠外科临床工作。

引用本文:

周海洋，魏学明，郑爱民，戴大江. BRAF基因突变对结肠癌伴随胃癌发生的影响[J]. 解放军预防医学杂志, 2016, 34(4): 544-546.
ZHOU Haiyang, WEI Xueming, ZHENG Aimin, DAI Dajiang. Effect of BRAF Gene Mutation on Colon Cancer and Associated With Gastric Cancer. Journal of Preventive Medicine of Chinese People's Liberation Army, 2016, 34(4): 544-546.

链接本文:

http://manu37.magtech.com.cn/Jwk_jsyxkx/jfj/CN/ 或 http://manu37.magtech.com.cn/Jwk_jsyxkx/jfj/CN/Y2016/V34/I4/544

(1) 乌兰图雅.结肠癌的流行病学及病因(J).中国实用乡村医生杂志,2012,19(13):10.
(2) 张振书,马强,结肠癌的流行病学(J).胃肠病学,2001,6(4):231.
(3) 刘晓红,曹永成,王翠翠.Lynch综合征相关结直肠癌患者的初步筛查(J).中华病理学杂志,2014,43(6):394.
(4) DOMINGO E P.LAIHO M,OLLIKAINEN M.BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing(J).J Med Genet,2004,41(9):664.
(5) 朱晓丽, 蔡旭, 张玲, 中国结直肠癌患者中KRAS与BRAF基因突变特征及其临床病理相关性(J).中华病理学杂志, 2012,41(9):584.
(6) DENG G I,BELL S,CRAWLEY J.BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer(J).Clin Cancer Res,2004,10(1 Pt1):191.
(7) ZLOBECI,BIHLH,SCHWARBL.TERRACCIANO,AND A.LUGLI,Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis(J).Int J Cancer, 2010,127(2):367.
(8) SHENHY,YUANHG,HUX,et al.Clinical significance of K-ras and BRAF mutations in Chinese colorectal cancer patients(J).World J Gastroenterol, 2011,17(6):809.
(9) MAMMOTOT,MUKAI M,MAMMOTO A,et al,Intravenous anesthetic,propofol inhibits invasion of cancer cells(J).Cancer Lett,2002,184(2):165.
(10) MIAOY,ZHANG Y,WAN H,et al.GABA-receptor agonist,propofol inhibits invasion of colon carcinoma cells(J).Biomed Pharmacother,2010,64(9):583.
(11) 高静,孙志伟,李艳艳,等.中国结直肠癌患者996例中KRAS和BRAF基因突变分析(J).中华病理学杂志,2012,41(9):579.
(12) ZHANG J,ZHANG D,WU GQ,et al.Propofol inhibits the adhesion of hepatocellular carcinoma cells by upregulating microRNA-199a and downregulating MMP-9 expression.(J).Hepatobiliary Pancreat Dis Int,2013,12(3):305.
(13) 金晶,闫竟一,薛向阳,等.miR-221和miR-222在胃癌中的表达及临床意义(J).肿瘤学杂志,2011,17(4):245.
(14) SHEN,H,Y.YUAN,H.G.HU,X.ZHONG,X.X.YE,M.D.LI,W.J.FANG,AND S.ZHENG,Clinical significance of K-ras and BRAF mutations in Chinese colorectal cancer patients(J).World J Gastroenterol,2011,17(6):809.
(15) SCHETTER A J,HARRIS,C C.Plasma microRNAs:a potential biomarker for colorectal cancer?(J). Gut,2009,58(10):1318.
(16) LEE E J,GUSEV Y,JIANG J,et al.Expression profiling identifies microRNA signature in pancreatic cancer(J).Int J Cancer,2007,120(5):104610.
(17) METZLER M,WILDA M,BUSCH K,et al.High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma(J).Genes Chromosomes Cancer, 2004,39(2):167.